Internet-based assessment of bowel symptoms and quality of life

European Journal of Gastroenterology and Hepatology

Volumn 18, Issue 12, 2006, Pages 1263-1269

  Enck, Paul ^a   Kowalski, Axel ^a   Martens, Ute ^a   Klosterhalfen, Sibylle ^b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Bowel symptoms; Epidemiology; Internet; Quality of life; Questionnaire

Indexed keywords

ADOLESCENT; ADULT; AGED; ANXIETY; ARTICLE; CONTROLLED STUDY; DEPRESSION; FAMILY ASSESSMENT; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INTERNET; INTESTINE SOUND; INVENTORY CONTROL; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SCORING SYSTEM; SELF CONTROL; VALIDITY; WELLBEING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEASIBILITY STUDIES; FEMALE; GASTROINTESTINAL DISEASES; GERMANY; HEALTH STATUS INDICATORS; HUMANS; INTERNET; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; REMOTE CONSULTATION;

EID: 33750936286     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.meg.0000243879.25067.32     Document Type: Article

References (43)

1. Eysenbach G, Wyatt J. Using the internet for surveys and health research. Med Internet Res 2002; 4:E13.
2. Saito YA, Talley NJ, Melton L, Fett S, Zinsmeister AR, Locke GR. The effect of new diagnostic criteria for irritable bowel syndrome on community prevalence estimates. Neurogastroenterol Motil 2003; 15:687-694.
3. Icks A, Haastert B, Enck P, Rathmann W, Giani G. Prevalence of functional bowel disorders and related health care seeking: a population-based study. Z Gastroenterol 2002; 40:177-183.
4. Talley NJ, Holtmann G, Agreus L, Jones M. Gastrointestinal symptoms and subjects cluster into distinct upper and lower groupings in the community: a four nations study. Am J Gastroenterol 2000; 95:1439-1447.
5. Hahn BA, Yan S, Strassels S. Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom. Digestion 1999; 60:77-81.
6. Gwee KA. Irritable bowel syndrome in developing countries: a disorder of civilization or colonization? Neurogastroenterol Motil 2005; 17:317-324.
7. Simren M, Brazier J, Coremans G, Dapoigny M, Muller-Lissner SA, Pace F, et al. Quality of life and illness costs in irritable bowel syndrome. Digestion 2004; 69:254-261.
8. Muller-Lissner SA, Pirk O. Irritable bowel syndrome in Germany. A cost of illness study. Eur J Gastroenterol Hepatol 2002; 14:1325-1329.
9. Dean BB, Aguilar D, Barghout V, Kahler KH, Frech F, Groves D, Ofman JJ. Impairment in work productivity and health-related quality of life in patients with IBS. Am J Manage Care 2005; 11 (Suppl):S17-S26.
10. Inadomi JM, Fennerty MB, Bjorkman D. Systematic review: the economic impact of irritable bowel syndrome. Aliment Pharmacol Ther 2003; 18:671-682.
11. Icks A, Hastert B, Enck P, Rathmann W, Giani G. Health-related quality of life in subjects with functional bowel disorders in Germany. Z Gastroenterol 2002; 40:863-867.
12. Longstreth GF, Bolus R, Naliboff B, Chang L, Kulich KR, Carlsson J, et al. Impact of irritable bowel syndrome on patients' lives: development and psychometric documentation of a disease-specific measure for use in clinical trials. Eur J Gastroenterol Hepatol 2005; 17:411-420.
13. Enck P, Klosterhalfen S, Kruis W. Factors affecting therapeutic placebo response rates in patients with irritable bowel syndrome. Nat Clin Pract Gastroenterol Hepatol 2005; 2:354-355.
14. Patel SM, Ock SM, Stason W, Legedza A, Conboy L, Kerr EC, et al. The placebo effect in irritable bowel syndrome (IBS) trials: a meta-analysis. Neurogastroenterol Motil 2005; 17:332-340.
15. Pitz M, Cheang M, Bernstein CN. Defining the predictors of the placebo response in irritable bowel syndrome. Clin Gastroenterol Hepatol 2005; 3:237-247.
16. Allescher HD, Enck P, Adler G, Hartung J, Manns MP, Riemann JF, et al. Epidemiologic long term follow-up in functional dyspepsia: characteristics of non-responders. Gastroenterology 2001; 120:A754.
17. Whitehead WE, Levy RL, Von Korff M, Feld AD, Palsson OS, Turner M, Drossman DA. The usual medical care for irritable bowel syndrome. Aliment Pharmacol Ther 2004; 20:1305-1315.
18. Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE. Appendix B. The Rome II modular questionnaire. In: Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE, editors. The functional gastrointestinal disorders. McLean Virginia: Degnon; 2000. pp. 670-688.
19. Dupuy H. The psychological general well-being (PGWB) index. In: Wenger NK, Mattson NE, Elison J, editors. Assessment of quality of life in clinical trials of cardiovascular therapies. Darien, Connecticut: Le Jacq Publishing Inc.; 1984. pp. 170-183.
20. Patrick DL, Drossman DA, Frederick IO, DiCesare J, Puder KL. Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Dig Dis Sci 1998; 43:400-411.
21. Hahn BA, Kirchdoerfer LJ, Fullerton S, Mayer E. Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life. Aliment Pharmacol Ther 1997; 11:553-559.
22. Enck P, Dubois D, Marquis P. Quality of life in patients with upper gastrointestinal symptoms. Results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol 1999; 34 (Suppl 231):48-54.
23. Naughton MJ, Wiklund I. A critical review of dimension-specific measures of health-related quality of life in cross-cultural research. Qual Life Res 1993; 2:397-432.
24. Thompson WG, Doteval G, Drossman DA, Heaton KW, Kruis W. Irritable bowel syndrome: guidelines for the diagnosis. Gastroenterol Int 1989; 2:92-95.
25. Bush N, Donaldson G, Moinpour C, Haberman M, Milliken D, Markle V, Lauson J. Development, feasibility and compliance of a web-based system for very frequent QOL and symptom home self-assessment after hematopoietic stem cell transplantation. Qual Life Res 2005; 14:77-93.
26. Rasmussen LM, Phanareth K, Noltre H, Backer V. Internet-based monitoring of asthma: a long-term, randomized clinical study of 300 asthmatic subjects. J Allergy Clin Immunol 2005; 115:1137-1142.
27. Drossman DA, Li Z, Andruzzi E, Temple R, Talley NJ, Thompson WG, et al. US householder survey of functional gastrointestinal disorders: prevalence, sociodemography and health impact. Dig Dis Sci 1993; 38:1569-1580.
28. Thompson WG, Irvine EJ, Pare P, Ferrazzi S, Ranze L. Functional gastrointestinal disorders in Canada. First population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci 2002; 47:225-235.
29. Payne S. Sex, gender, and irritable bowel syndrome: making the connections. Gend Med 2004; 1:18-28.
30. Wiklund IK, Junghard O, Grace E, Talley NJ, Kamm M, Veldhuyzen van Zanten S, et al. Quality of life in reflux and dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl 1998; 583:41-49.
31. Chassany O, Marquis P, Scherrer B, Read NW, Finger T, Bergmann JF, et al. Validation of a specific quality of life questionnaire for functional digestive disorders. Gut 1999; 44:527-533.
32. Talley NJ, Haque M, Wyeth JW, Stace NH, Tytgat GN, Stanghellini V, et al. Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index. Aliment Pharmacol Ther 1999; 13:225-235.
33. Wiklund IK, Fullerton S, Hawkey CJ, Jones RH, Longstreth GF, Mayer EA, et al. An irritable bowel syndrome-specific symptom questionnaire: development and validation. Scand J Gastroenterol 2003; 38:947-954.
34. Longstreth GF, Bolus R, Naliboff B, Chang L, Kulich KR, Carlsson J, et al. Impact of irritable bowel syndrome on patients' lives: development and psychometric documentation of a disease-specific measure for use in clinical trials. Eur J Gastroenterol Hepatol 2005; 17:411-420.
35. Frank L, Kleinman L, Rentz A, Ciesla G, Kim JJ, Zacker C. Health-related quality of life associated with irritable bowel syndrome: comparison with other chronic diseases. Clin Ther 2002; 24:675-689.
36. McGee HM, O'Boyle CA, Hickey A, O'Malley K, Joyce CR. Assessing the quality of life of the individual: the SEIQoL with a healthy and a gastroenterology unit population. Psychol Med 1991; 21:749-759.
37. Akehurst RL, Brazier JE, Mathers N, O'Keefe C, Kaltenthaler E, Morgan A, et al. Health-related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting. Pharmacoeconomics 2002; 20:455-462.
38. Dean BB, Aguilar D, Barghout V, Kahler KH, Frech F, Groves D, Ofman JJ. Impairment in work productivity and health related quality-of-life in patients with IBS. Am J Manag Care 2005;11 (Suppl): S17-S26.
39. Cash B, Sullivan S, Barghout V. Total costs of IBS: employer and managed care perspective. Am J Manag Care 2005; 11 (Suppl): S7-S16.
40. Lembo A, Ameen VZ, Drossman DA. Irritable bowel syndrome: towards understanding of severity. Clin Gastroenterol Hepatol 2005; 3:717-725.
41. Drossman DA, Li Z, Toner BB, Diamant NE, Creed FH, Thompson D, et al. Functional bowel disorders. A multicenter comparison of health status and development of illness severity index. Dig Dis Sci 1995; 40:986-995.
42. Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997; 11:395-402.
43. Longstreth GF, Yao JF. Irritable bowel syndrome and surgery: a multivariate analysis. Gastroenterology 2005; 126:1665-1673.